MilliporeSigma
Search Within
Document Type

112-47-0

Applied Filters:
Keyword:'112-47-0'
Showing 1-30 of 110 results for "112-47-0" within Technical Documents
MILLIPLEX®MAP Human Myokine Panel is an optimized quantitative immunoassay that simultaneously measures 15 novel muscle-secreted factors
16 17 5749 41 27 89 15 47 25 32 31 125 25 19 11 17 16 5680 42 27 95 15 47 25 31 29 125 27 LIF std 4 18 12 15 16 100 1296
Product Information Sheet - F4883
Plasma Proteins, 2nd Ed., Vol. 1, Putnam, F.W., Ed., Academic Press (New York, NY: 1975) p. 66-112. 2. Marder, V.J., et al., High molecular weight derivatives of human fibrinogen produced by plasmin
LABORATORY NOTEBOOK ISSUANCE PAGE
01 22 22 .9 90 24 .3 05 39 .0 98 40 .0 78 85 .4 68 87 .6 2 13 2. 91 13 7. 33 (2 23 ) (2 26 ) 44 .9 56 47 .8 67
LABORATORY NOTEBOOK ISSUANCE PAGE
01 22 22 .9 90 24 .3 05 39 .0 98 40 .0 78 85 .4 68 87 .6 2 13 2. 91 13 7. 33 (2 23 ) (2 26 ) 44 .9 56 47 .8 67
LABORATORY NOTEBOOK ISSUANCE PAGE
01 22 22 .9 90 24 .3 05 39 .0 98 40 .0 78 85 .4 68 87 .6 2 13 2. 91 13 7. 33 (2 23 ) (2 26 ) 44 .9 56 47 .8 67
Application Note Anaerobic EM using ICR+
days C. sporogenes ATCC 19404 (111)/78/98 ø = 88 99/97 112 6 – 11 N/A N/A C. sporogenes ATCC 11437 42 / 56 / 47 ø = 48 58/47 110 5.5 – 12 N/A N/A P. acnes
Periodic Table of the Elements - Certipur ICP multi-element standards according to USP <232> - EMD
, 3, 4, 5 [Kr] 4d85s1 46 106.42 1554.9 2963 1.30Pd 0, 2, 4 [Kr] 4d10 47 107.87 961.78 2162 1.42Ag 1, 2 [Kr] 4d105s1 48 112.41 321.07 767 1.46Cd 2 [Kr] 4d105s2
Enhanced Sensitivity Immunogenicity (ADA) Assay - Next Generation SMC™ Technology
0.00 68 39 22 2 0.05 72 37 20 80 0.15 68 35 22 162 0.46 68 47 23 357 1.37 92 49 25 988 4.12 110 60 34 2090 12.35 206 112 55 2946 37.04 491 230 125 5892 111.11 897 647 265 8293 333.33 2318 1767 999
RonaCare Allantoin
. ARCO Tower, 5 F 8-1, Shimomeguro 1-chome Meguro ku Tokyo 153 Japan Phone: +81-3-54 34-47 11 Fax: +81-3-54 34-47 04 Internet: www.merck.co.jp E-mail: merckcos@merck.co.jp
Periodic table A4
45 102.91 1964 3695 1.45 Rh 0, 1, 2, 3, 4, 5 [Kr] 4d85s1 46 106.42 1554.8 2963 1.30 Pd 0, 2, 4 [Kr] 4d10 47 107.87 961.78 2162 1.42
Spare parts for Mobius® FlexReady Solution with Smart Flexware® Assemblies For Chromatography and TFF
with Pumps—Skid 116 115 100 98 104 99 1 110 112 100 116 104 1 115 110 98 99 112
Examination of Non-Specifically Bound Proteins and Peptides Following Depletion of Twenty High Abundance Proteins from Human Plasma
Fragment)” 77 1 111 1 112 1 110 1 54 1 IPI00022463 Serotransferrin precursor 393 8 131 3 551 11 193 6 571 11 543 11 67 1 194 5 828 14 1051 19 IPI00022432 Transthyretin precursor
Periodic table Poster
, 3, 4, 5 [Kr] 4d85s1 46 106.42 1554.8 2963 1.30Pd 0, 2, 4 [Kr] 4d10 47 107.87 961.78 2162 1.42Ag 1, 2 [Kr] 4d105s1 48 112.41 321.07 767 1.46Cd 2 [Kr]
Corticotropin-Releasing Factor Receptor Antagonists- Potential Novel Therapies for Human Disease
d e r : 1 . 8 0 0 . 3 2 5 . 3 0 1 0 ( U S ) T e c h n i c a l S
Validation and Qualification for Durapore&reg; Sterilizing-Grade (0.22 &micro;m) Membrane VMF4
6.75 105 30 14.0 >8.36 90 24 12.9 6.88 110 31 14.8 >8.36 113 56 13.4 6.98 114 32 15.2 >8.36 112 57 13.5 7.08 105 33 14.8 >8.36 116 44 14.2
Protein Tyrosine Phosphatases- Potential Roles in Disease
d e r : 1 . 8 0 0 . 3 2 5 . 3 0 1 0 ( U S ) T e c h n i c a l S
59505 Galactosyltransferase Kit
GlcNAc-hexanolamine  -Gal(14)- -GlcNAc- hexanolamine 47 -GlcNAc-hexanolamine-agarose  -Gal(14)- -GlcNAc- hexanolamine-agarose 47 -GlcNAc(14)-Gal-OH  -Gal(14)--GlcNAc(14)-Gal-
ExPlore with Confidence: Prestige Antibodies Breast Cancer Research
ICC-IF in human cell line A-431, strong staining of plasma membrane is shown in green. 220 112 84 47 32 26 17 kDa 1 2 3
Protocol: Human Kidney Injury Magnetic Bead Panel 6
Samples RBP4 104% 106% β-2-Microglobulin 133% 107% Clusterin 104% 104% Cystatin C 103% 112% HKI6MAG-99K Rev. 07-JUN-2017 PAGE 17
Protocol- HKI6MAG-99K
Samples RBP4 104% 106% β-2-Microglobulin 133% 107% Clusterin 104% 104% Cystatin C 103% 112%
An Update on Ligands for Prostanoid Receptors
. Nishizawa, E.E., et al., Prostaglandins, 9, 109-121 (1975). 16. Toda, N., Prostaglandins, 23, 99-112 (1982). 17. Flower, R.J., et al., Br. J. Pharmacol., 56, 229-233 (1976). 18. Town, M.H., et al., Prostaglandins
Protocol: Human Kidney Injury Magnetic Bead Panel 2
Hour Protocol % Recovery in Serum Matrix % Recovery in Serum Matrix EGF 109% 112% Lipocalin-2/NGAL 107% 104% Albumin 102% 106% Clusterin 107% 104%
Perfection in every dimension 2014. Inorganic reagents Catalogue
P M S, 3 0 el em en ts Or d. N o. 1 .1 05 80 .0 10 0 M ul ti- el em en t s ta nd ar d XX I
Virus Retention Performance of Viresolve®Pro Devices under a Range of Processing Conditions
Release on Virus Capture During Virus Filtration Using Confocal Microscopy. Biotechnol. and Bioeng., 112 (10), 2115-2122. 13. Fallahianbijan, F., Giglia, S., Carbrello, C., & Zydney, A.L. (2017) Use
White Paper: Improving Solubility
in marketed amorphous drug products. European Journal of Pharmaceutics and Biopharmaceutics, 2017. 112: p. 204-208. 20. Cadogan, D.F. and C.J. Howick, Plasticizers, in Ullmann's Encyclopedia of Industrial
Lymphocyte Enzymes Procedure
a-naphthyl acetate esterase activity in human lymphocytes: Usefulness as a T-cell marker. Cell Immunol 35:112, 1978 20. Knowles DM II, Halper JP: Human medullary and cortical thymocytes are distinguishable
Product Information Sheet - 104100
ALKALINE PHOSPHATASE'2,.. Adults. 0.8-3.0 Sigma Units/ml (13-50 U/I) Children: 2.8-6.7 Sigma Units/ml (47-112 U/I) NORMAL TOTAL SERUM ACID PHOSPHATASE'3 Males: 0.13-0.63 Sigma Units/mi (2-11 U/I) Females:
Product Information Sheet - 10440
ALKALINE PHOSPHATASE'2,.. Adults. 0.8-3.0 Sigma Units/ml (13-50 U/I) Children: 2.8-6.7 Sigma Units/ml (47-112 U/I) NORMAL TOTAL SERUM ACID PHOSPHATASE'3 Males: 0.13-0.63 Sigma Units/mi (2-11 U/I) Females:
Product Information Sheet - 104105
ALKALINE PHOSPHATASE'2,.. Adults. 0.8-3.0 Sigma Units/ml (13-50 U/I) Children: 2.8-6.7 Sigma Units/ml (47-112 U/I) NORMAL TOTAL SERUM ACID PHOSPHATASE'3 Males: 0.13-0.63 Sigma Units/mi (2-11 U/I) Females:
Page 1 of 4
Page 1 of 4